Page last updated: 2024-08-21

glycerylphosphorylcholine and vb-201

glycerylphosphorylcholine has been researched along with vb-201 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breitbart, E; Feige, E; Halperin, G; Ishai, E; Mendel, I; Propheta-Meiran, O; Shoham, A1
Feige, E; George, J; Harats, D; Mendel, I; Yacov, N1
Breitbart, E; Feige, E; George, J; Hait-Darshan, R; Harats, D; Levi, I; Mendel, I; Polonsky, O; Propheta-Meiran, O; Salem, Y; Shoham, A; Yacov, N1
Breitbart, E; Feige, E; George, J; Harats, D; Ishai, E; Levi, I; Mendel, I; Propheta-Meiran, O; Salem, Y; Shoham, A; Yacov, N1
Breitbart, E; Ishai, E; Mendel, I; Shoham, A; Yacov, N1
Breitbart, E; Feldman, B; Ishai, E; Mendel, I; Volkov, A; Yacov, N1

Reviews

1 review(s) available for glycerylphosphorylcholine and vb-201

ArticleYear
Modified phospholipids as anti-inflammatory compounds.
    Current opinion in lipidology, 2010, Volume: 21, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atherosclerosis; Dendritic Cells; Disease Models, Animal; Epigenesis, Genetic; Glycerylphosphorylcholine; Humans; Inflammation; Mice; Multiple Sclerosis; Oxidation-Reduction; Phospholipids; Psoriasis; Rabbits; Signal Transduction; Toll-Like Receptors

2010

Trials

1 trial(s) available for glycerylphosphorylcholine and vb-201

ArticleYear
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.
    Clinical and experimental immunology, 2014, Volume: 175, Issue:1

    Topics: Animals; Atherosclerosis; Cholesterol; Glycerylphosphorylcholine; HEK293 Cells; Humans; Immunity, Innate; Lipopolysaccharide Receptors; Male; Mice; Monocytes; Rabbits; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4

2014

Other Studies

4 other study(ies) available for glycerylphosphorylcholine and vb-201

ArticleYear
A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.
    Journal of neuroimmunology, 2010, Sep-14, Volume: 226, Issue:1-2

    Topics: Animals; Bone Marrow Cells; Bromodeoxyuridine; CD4 Antigens; Cell Differentiation; Central Nervous System; Cytokines; Dendritic Cells; Disease Models, Animal; Drug Interactions; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Forkhead Transcription Factors; Freund's Adjuvant; Glycerylphosphorylcholine; Glycoproteins; Ionomycin; Ionophores; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Pertussis Toxin; Phosphorylcholine; Polymethacrylic Acids; Severity of Illness Index; T-Lymphocytes; Time Factors

2010
Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.
    Atherosclerosis, 2013, Volume: 229, Issue:2

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis; Cholesterol; Disease Models, Animal; Female; Flow Cytometry; Glycerylphosphorylcholine; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Peritonitis; Receptors, Chemokine; Signal Transduction; Triglycerides; Vasculitis

2013
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:9

    Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blotting, Western; Cell Movement; Cytokines; Dendritic Cells; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycerophosphates; Glycerylphosphorylcholine; Hepatic Stellate Cells; Humans; Inflammation; Kupffer Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Phospholipids; Pyridinium Compounds; Real-Time Polymerase Chain Reaction; Telmisartan; Toll-Like Receptor 2; Toll-Like Receptor 4; Triglycerides

2016
Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats.
    Basic & clinical pharmacology & toxicology, 2019, Volume: 124, Issue:2

    Topics: Animals; Blood Cells; Collagen; Disease Models, Animal; Fibronectins; Glomerulosclerosis, Focal Segmental; Glycerophosphates; Glycerylphosphorylcholine; Kidney; Macrophages; Male; Monocytes; Nephrectomy; Podocytes; Pyridinium Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 2; Toll-Like Receptor 4; Transforming Growth Factor beta

2019